🇺🇸 dexmedetomidine plus ketamine in United States

dexmedetomidine plus ketamine (dexmedetomidine plus ketamine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

dexmedetomidine plus ketamine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is dexmedetomidine plus ketamine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for dexmedetomidine plus ketamine in United States?

Benha University is the originator. The local marketing authorisation holder may differ — check the official source linked above.